27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Gainers
• Genprex, Inc. (NASDAQ:GNPX) shares rose 48.7% to $1.71 during Wednesday's pre-market session.
• Akcea Therapeutics, Inc. (NASDAQ:AKCA) shares moved upwards by 16.6% to $20.21. The most recent rating by BMO Capital, on November 06, is at Outperform, with a price target of $36.00.
• Advaxis, Inc. (NASDAQ:ADXS) stock surged 5.8% to $1.10.
• Moderna, Inc. (NASDAQ:MRNA) stock increased by 5.3% to $22.05. The most recent rating by Bank of America, on December 03, is at Buy, with a price target of $29.00.
• BioLine Rx, Inc. (NASDAQ:BLRX) stock surged 4.0% to $2.59.
Losers
• Novavax, Inc. (NASDAQ:NVAX) shares plummeted 13.4% to $8.50 during Wednesday's pre-market session.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!